Chronic Stress and Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
Progress Against Cancer
Accumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
Study finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
The FDA has approved a new antibody-drug conjugate to treat two types of non-Hodgkin B-cell lymphomas The U.S. Food and Drug Administration (FDA) has approved polatuzumab vedotin-piiq (Polivy), in combination with a rituximab product,...
This is the first modified, donor cord blood–based stem cell therapy approved to reduce time to hematopoietic recovery and infection The U.S. Food and Drug Administration (FDA) approved omidubicel-onlv (Omisirge) for adult and pediatric...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating KRAS: A 30-year Overnight Sensation.” The plenary session was chaired by Dafna Bar-Sagi, PhD, FAACR,...
Treatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.
The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career development of meritorious early-career scientists from countries building cancer research capacities. This month, the GSITA...
Attentive care can manage conditions that cause patients to seek emergency care, but patients with concerning symptoms should still go to the hospital or urgent care center.
New therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.
The researchers are interested in understanding why some lesions turn into pancreatic cancer to better identify those with a high risk of the disease. A surprisingly large number of healthy people may be walking...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now